| Literature DB >> 31976139 |
Cláudia Daniela Barbian1, Cézane Priscila Reuter2, Jane Dagmar Pollo Renner3, Priscila Tatiana da Silva1, Elisa Inês Klinger1, James Philip Hobkirk4, Andréia Rosane de Moura Valim3, Miria Suzana Burgos2.
Abstract
Few studies show the potential changing effect of fat-mass and obesity-associated ( FTO ) rs9939609 gene on cardiometabolic risk after a lifestyle intervention. This study aims to evaluate whether overweight and obese adolescents, carriers of the risk genotypes for obesity of the FTO rs9939609 gene polymorphism, have different anthropometric and biochemical responses to an interdisciplinary intervention program. The quasi-experimental study involved 34 adolescents aged 10 to 15 years. Schoolchildren with AA/AT genotype decreased glucose, total cholesterol, low-density lipoprotein cholesterol, and increased high-density lipoprotein cholesterol. However, there were no differences between the genotypes, suggesting that the "A" allele did not modify the subject's response to the intervention program. © Thieme Medical Publishers.Entities:
Keywords: clinical trial; genetic polymorphism; obesity
Year: 2019 PMID: 31976139 PMCID: PMC6976332 DOI: 10.1055/s-0039-3399511
Source DB: PubMed Journal: J Pediatr Genet ISSN: 2146-460X